On this episode of Stock Movers: - Novo Nordisk (NVO) shares rise after news that it's slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx ...

GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...

GoodRx's telemedicine service offers oral semaglutide for weight loss, with initial pricing of $149 for 1.5 mg and 4 mg doses ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...

Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. | SAN FRANCISCO — Surescripts is ...

*Price is based on the smallest unit of the medication that a patient can purchase; prices will vary based on how many units are required for the number of doses needed. **GoodRx prices are based on ...